- Condition: Rheumatoid Arthritis
Intervention: Drug: anti-TNF withdrawal (tanercept, adalimumab, infliximab, certolizumab, golimumab)
Sponsors: Medical University of Graz; Medical University of Graz
Not yet recruiting - verified May 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: JNJ-40346527; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Systemic Vasculitis
Intervention: Other: Resistance Exercise
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified May 2012 - Conditions: Axial and Peripheral Spondyloarthritis; Rheumatoid Arthritis
Interventions: Drug: administration of Cimzia®; Drug: Immunoscintigraphy with radiolabeled Cimzia®.
Sponsors: University Hospital, Ghent; University Hospital, Ghent; UCB Pharma SA
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: VX-509; Drug: VX-509 matching placebo
Sponsors: Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals Incorporated
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University; Arthritis Foundation
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: No Intervention (subjects were previously treated with Orencia®)
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche; Clalit Health Services
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: placebo
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Crohn's Disease
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: LY2127399
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified April 2012 - Conditions: Chemical Injuries; Unspecified Complication of Corneal Transplant; Autoimmune Diseases; Ocular Cicatricial Pemphigoid; Stevens Johnson Syndrome; Lupus Erythematosus, Systemic; Rheumatoid Arthritis; Other Autoimmune Diseases
Intervention: Drug: Riboflavin
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary
Recruiting - verified April 2012 - Condition: Inflammatory Joint Diseases
Intervention:
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University Hospital of North Norway; St. Olavs Hospital; Lillehammer Hospital for Rheumatic Diseases; Vestre Viken HF Drammen Hospital
Recruiting - verified April 2012 - Conditions: Osteoarthritis (OA); Rheumatoid Arthritis (RA); Ankylosing Spondylitis (AS)
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: MK-8457 100 mg; Drug: MK-8457 100 mg; Drug: Dose-Matched Placebo; Drug: MK-8457 200 mg; Drug: MK-8457 25 mg; Drug: MK-8457
Sponsors: Merck; Merck
Not yet recruiting - verified April 2012 - Condition: Cardiovascular Check-up in Patients With Rheumatoid Arthritis
Intervention: Other: Cardiovascular check-up
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified March 2012 - An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: ASP015K; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.
Not yet recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: fostamatinib; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Infliximab; Biological: Infliximab
Sponsors: Nichi-Iko Pharmaceutical Co.,Ltd.; Nichi-Iko Pharmaceutical Co.,Ltd.
Recruiting - verified March 2012 - Conditions: Inflammation; Rheumatoid Arthritis
Interventions: Drug: NNC0114-0006; Drug: placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Adalimumab; Drug: Current adalimumab
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: MEDI5117; Biological: MEDI5117 Placebo
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab, Abatacept; Drug: Tocilizumab, Abatacept
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Ministry of Health, France
Not yet recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Folic Acid; Drug: Placebo
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Iguratimod
Sponsors: Jiangsu Simcere Pharmaceutical R&D Co. Ltd.; Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Cyberonics VNS System
Sponsors: SetPoint Medical Corporation; SetPoint Medical Corporation
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Cyberonics VNS System
Sponsors: SetPoint Medical Corporation; SetPoint Medical Corporation
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Triple Therapy; Drug: TNF inhibitors
Sponsors: Columbia University; Columbia University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Iguratimod; Drug: Methotrexate
Sponsors: Jiangsu Simcere Pharmaceutical R&D Co. Ltd.; Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Not yet recruiting - verified March 2012 - Condition: Arthritis, Rheumatoid
Interventions: Other: Supervised high-intensity exercise programme; Other: Exercise programme
Sponsors: Aarhus University Hospital; Aarhus University Hospital
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: insoles intervention; Other: placebo insole
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2012 - Conditions: Autoimmune Diseases; Sjogren's Syndrome; Dry Eye
Interventions: Drug: Hydroxychloroquine; Drug: Placebo
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Gruppo Italiano Studio Early Arthritis; Gruppo Italiano Studio Early Arthritis
Recruiting - verified February 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: RoActemra/Actemra (tocilizumab)
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)
Sponsors: Alliancells Bioscience Corporation Limited; Alliancells Bioscience Corporation Limited
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: etanercept; Drug: methotrexate
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: rituximab
Sponsors: Celltrion; Celltrion
Not yet recruiting - verified February 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: 800 mg ibuprofen/26.6 mg famotidine
Sponsors: Horizon Pharma, Inc.; Horizon Pharma, Inc.; Pediatric Rheumatology Collaborative Study Group
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Peer Support Program
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Amgen
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: PF-05280586; Biological: MabThera; Biological: Rituxan
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: UCB, Inc.; UCB, Inc.; ReSearch Pharmaceutical Services, Inc.
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Givinostat
Sponsors: Italfarmaco; Italfarmaco; Parexel
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Not yet recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training; Behavioral: Online disease education
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting - verified February 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Interventions: Drug: VIMOVO; Drug: VIMOVO; Drug: VIMOVO
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Varicella Zoster
Intervention: Drug: Zostavax (varicella zoster virus) vaccine
Sponsors: Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Tacrolimus
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc; Astellas Pharma Korea, Inc.
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Certolizumab pegol + Methotrexate (CZP + MTX); Biological: Adalimumab + Methotrexate (ADA + MTX)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Conditions: Premature Endothelial Dysfunction; Rheumatoid Arthritis; Healthy
Intervention:
Sponsors: Orrin M Troum, M.D. and Medical Associates; Orrin M Troum, M.D. and Medical Associates; Bristol-Myers Squibb
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Non-biological DMARD's; Biological: Cimzia, Orencia, RoActemra
Sponsors: Karolinska Institutet; Karolinska Institutet
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Pope Research Corporation; Pope Research Corporation
Not yet recruiting - verified December 2011 - Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: Adalimumab
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: vascular occlusion with exercise trainig; Other: high intensity resistance training; Other: control
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Optimus Clinical Research; Optimus Clinical Research; Arthritis Australia, Abbott Australia
Recruiting - verified November 2011 - Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550 or Placebo; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified April 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3-and 4-part Proximal Humeral Fractures; Avascular Necrosis; Gross Rotator Cuff Deficiency; Failed Total Shoulder Arthroplasty (Both Glenoid and Humeral Components Require Revision
Intervention: Device: Trabecular Metal Reverse Shoulder System
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis; Ununited Humeral Head Fracture; Irreducible 3- and 4-part Proximal Humeral Fractures; Avascular Necrosis
Intervention: Device: Trabecular Metal Humeral Stem
Sponsors: Zimmer, Inc.; Zimmer, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab; Drug: tocilizumab
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: LY3009104; Drug: Placebo; Drug: LY3009104; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012 - Conditions: Osteoarthritis, Hip; Arthritis, Rheumatoid; Femur Head Necrosis
Interventions: Procedure: Manual Intervention; Procedure: Navigated Intervention
Sponsors: Aesculap AG; Aesculap AG
Recruiting - verified December 2011 - Conditions: Lupus Erythematosus, Systemic; Arthritis, Rheumatoid
Intervention:
Sponsors: Federal University of São Paulo; Federal University of São Paulo
Recruiting - verified November 2011 - Conditions: Arthritis; Rheumatoid
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Olokizumab 60 mg; Biological: Olokizumab 120 mg; Biological: Olokizumab 240 mg
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis; Other Arthritic Conditions (e.g., Psoriatic Arthritis)
Intervention: Behavioral: painACTION: Arthritis
Sponsors: Inflexxion, Inc.; Inflexxion, Inc.
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: BT061; Biological: Placebo
Sponsors: Biotest; Biotest
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis, Arthritis, Juvenile Rheumatoid
Intervention: Drug: Tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified April 2012 - Condition: Primary Sjogren´s Syndrome
Intervention: Other: Aerobic exercise
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified January 2012 - Condition: Vaccine Response Impaired
Interventions: Biological: hepatitis A vaccine; Biological: hepatitis A vaccine
Sponsors: Sormland County Council, Sweden; Sormland County Council, Sweden
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: Certolizumab pegol
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: placebo of CDP870; Drug: CDP870
Sponsors: Otsuka Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; UCB Japan Co., LTD.
Recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Not yet recruiting - verified November 2011 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: tDMARDs; Drug: biodmards
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis; Developmental Dysplasia of the Hip
Intervention:
Sponsors: Wirral University Teaching Hospital NHS Trust; Hussain Kazi
Not yet recruiting - verified September 2011 - Condition: Influenza
Interventions: Biological: 2011-2012 Sanofi Pasteur Fluzone®; Biological: 2011-2012 Sanofi Pasteur Fluzone® High Dose
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Sjogrens Syndrome
Intervention:
Sponsors: Göteborg University; Göteborg University
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Revamilast; Drug: Revamilast; Drug: Revamilast; Drug: Placebo Comparator
Sponsors: Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals SA
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: SC anti-TNF
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Cytokine Environment; Kinetics of Bone Cells Differentiation and Activity in Untreated RA and AS Patients.
Intervention:
Sponsors: Instituto de Medicina Molecular; Instituto de Medicina Molecular; Merck
Not yet recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo to Secukinumab (AIN457); Biological: Secukinumab
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Acute Rheumatoid Arthritis
Intervention: Drug: s.c. injections of bovine intestinal Alkaline Phosphatase
Sponsors: Alloksys Life Sciences B.V.; Alloksys Life Sciences B.V.; Aix Scientifics
Recruiting - verified August 2011 - Conditions: Interstitial Lung Disease; Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
Sponsors: University of Michigan; University of Michigan
Recruiting - verified December 2011 - Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
Sponsors: University of Southern California; University of Southern California; Teva Pharmaceuticals USA
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: masitinib; Drug: masitinib; Drug: methotrexate
Sponsors: AB Science; AB Science
Recruiting - verified May 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: MRC375; Drug: Matching Placebo; Drug: MRC375 150mg
Sponsors: Molecular Research Center, Inc.; Molecular Research Center, Inc.; Camargo Pharmaceutical Services; Rho; Clin Data Services; Harrison Clinical Research; BARC Global Central Laboratory; Bilcare Global Clinical Supplies
Recruiting - verified January 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Blood Transfusion Centre of Slovenia; Blood Transfusion Centre of Slovenia; University Medical Centre Ljubljana
Not yet recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: No intervention
Sponsors: Rigshospitalet, Denmark; Rigshospitalet, Denmark
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: BMS-817399; Drug: BMS-817399
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
Sponsors: University of Washington; University of Washington
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: ISIS CRP Rx or Placebo
Sponsors: Isis Pharmaceuticals; Isis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Teriparatide
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Eli Lilly and Company
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Sjogren's Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Osteoarthritis; Post-traumatic Arthritis
Intervention: Device: Ascension MCP Finger Implant
Sponsors: Ascension Orthopedics, Inc.; Ascension Orthopedics, Inc.
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Prednisolone
Sponsors: Rheumazentrum Ruhrgebiet; Rheumazentrum Ruhrgebiet
Not yet recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Reumatocept (etanercept); Drug: Enbrel (etanercept)
Sponsors: EMS; EMS
Not yet recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: MK-8808 500 mg/m^2; Biological: Rituximab 500 mg/m^2; Drug: Methotrexate; Biological: MabThera (rituximab) 500 mg/m^2; Biological: Rituxan (rituximab) 500 mg/m^2; Biological: MK-8808 1000 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Juvenile Idiopahtic Arthritis
Intervention: Drug: etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
Sponsors: The Rheumatological Center of Helsinki; The Rheumatological Center of Helsinki; Abbott
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University Hospital Muenster; University Hospital Muenster
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Pathogenesis; Sjogren's Syndrome; Salivary Gland
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified January 2012 - Conditions: Arthritis; Rheumatoid; High Dose
Intervention: Drug: Methotrexate (MTX)
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Arthritis, Juvenile Rheumatoid
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Dry Eye; Sjogren's Syndrome; Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
Sponsors: Michigan Cornea Consultants, PC; Michigan Cornea Consultants, PC; Kresge Eye Institute
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Secukinumab (75 mg); Drug: Secukinumab (150 mg); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid ArthritisCondition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Open Label Drug Certolizumab Pegol (CZP); Procedure: Arthroscopic synovial tissue biopsy
Sponsors: Arthritis Treatment Center, Maryland; Nathan Wei, MD, FACP, FACR:; University of California, San Diego
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: BMS-945429 Placebo; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Drug: Methotrexate; Drug: Methotrexate; Drug: Methotrexate Placebo; Drug: Methotrexate; Drug: Adalimumab Placebo; Drug: Adalimumab
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Prednisolone; Drug: dipyridamole; Drug: Prednisone; Drug: prednisolone-dipyridamole; Other: placebo
Sponsors: Zalicus; Zalicus
Recruiting - verified June 2011 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Istituto Giannina Gaslini; Istituto Giannina Gaslini; Members of the PRINTO network (PRINTO at www.printo.it)
Not yet recruiting - verified May 2011 - Condition: Rheumatoid Arthritis
Intervention: Other: Observational study
Sponsors: Canadian Research & Education in Arthritis; Canadian Research & Education in Arthritis; Abbott
Recruiting - verified November 2011 - Conditions: Arthrodesis; Degenerative Arthritis; Rheumatoid Arthritis; Complications; Arthroplasty, Mechanical
Intervention:
Sponsors: Wright Medical Technology; Wright Medical Technology; Duke University
Recruiting - verified June 2011 - Conditions: Rheumatoid Arthritis; Inflammation
Interventions: Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified January 2012 - Conditions: Rheumatoid Arthritis of Ankle; Osteoarthritis of Ankle; Traumatic Arthritis of Ankle
Intervention:
Sponsors: Orthopaedic Associates of Michigan, PC; Orthopaedic Associates of Michigan, PC
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: secukinumab; Biological: secukinumab; Biological: placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: MORAb-022
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified March 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis
Intervention: Drug: Enbrel
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo; Biological: Abatacept
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Tocilizumab+Methotrexate(MTX)
Sponsors: Chugai Pharma Taiwan; Chugai Pharma Taiwan
Recruiting - verified April 2012 - Conditions: Autoimmune Diseases; Systemic Inflammatory Process; Knee Pain Chronic; Osteoarthritis; Rheumatoid Arthritis
Interventions: Drug: Fish Oil; Drug: Vitamin D; Other: placebo pill
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Special Investigation in Patients With Rheumatoid Arthritis (HOPE3 Study Follow up Survey (P12-069))Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Early Inflammatory Arthritis
Intervention: Behavioral: Peer Mentor Training
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; The Arthritis Society, Canada; Mount Sinai Hospital, Toronto; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Early Inflammatory Arthritis
Interventions: Behavioral: One-on-one peer support; Behavioral: Standard of care
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Rheumatology Association; Mount Sinai Hospital, Toronto; The Arthritis Society, Canada; St. Michael's Hospital, Toronto; University of Toronto
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Conditions: Rheumatoid Arthritis; Pregnancy; TNFalfa Inhibitors; Preconceptional Counselling; Disease Activity
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center; Dutch Association of Rheumatology NVR
Recruiting - verified November 2011 - Conditions: Uveitis; Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody; Drug: placebo
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Abbott
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: Subcutaneous Abatacept
Sponsors: Orrin M Troum, M.D. and Medical Associates; Orrin M Troum, M.D. and Medical Associates; Bristol-Myers Squibb
Recruiting - verified December 2011 - Condition: Cardiovascular Disease, Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: etanercept
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis
Intervention:
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: naproxen; Drug: esomeprazole
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: rituximab [MabThera/Rituxan]; Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: etanercept
Sponsors: Amgen; Amgen
Recruiting - verified March 2012 - Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Intervention: Drug: Simponi®
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis
Interventions: Device: Augment(tm) Injectable Bone Graft; Procedure: Autologous bone graft
Sponsors: BioMimetic Therapeutics; BioMimetic Therapeutics
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: MT203; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: TcLand Expression S.A.; TcLand Expression S.A.; Premier Research Group plc; Theradis pharma; Medpharmgene Inc.
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: CDP6038
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: therapy with disease-modifying anti rheumatic drugs (DMARD)
Sponsors: University of Zurich; University of Zurich
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Osteoporosis; Osteopenia
Interventions: Biological: Ibandronate; Biological: Placebo
Sponsors: Seoul National University Hospital; Yeong-Wook Song
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: adalimumab; Drug: Placebo; Drug: Placebo; Drug: methotrexate; Drug: folate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Sjogren's Syndrome; Xerostomia
Intervention: Drug: Dexamethasone
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Postmenopausal Osteoporosis; Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Denosumab
Sponsors: Amgen; Amgen
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: GP2013; Biological: rituximab
Sponsors: Sandoz; Sandoz; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
Sponsors: Keio University; Keio University; Saitama Medical University
Recruiting - verified December 2010 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and placebo of fostamatinib; Drug: Placebo of fostamatinib, fostamatinib, and placebo injections
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: Tocilizumab + methotrexate(MTX); Drug: Tocilizumab placebo + methotrexate(MTX)
Sponsors: Chugai Pharma Taiwan; Chugai Pharma Taiwan
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
Sponsors: University Hospital, Tours; University Hospital, Tours
Recruiting - verified June 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: DMARD
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: Placebo, then certolizumab pegol (CZP); Biological: Certolizumab pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified January 2012 - Conditions: Primary Arthrosis; Post Traumatic Arthritis; Rheumatoid Arthritis; Osteoarthritis
Intervention: Device: Scandinavian Total Ankle Replacement System (STAR Ankle)
Sponsors: Small Bone Innovations, Inc.; Small Bone Innovations, Inc.
Recruiting - verified March 2012 - Condition: Polyarticular Course Juvenile Idiopathic Arthritis
Intervention: Drug: Givinostat
Sponsors: Italfarmaco; Italfarmaco
Recruiting - verified January 2012 - Condition: Primary Arthrosis
Intervention: Device: Scandinavian Total Ankle Replacement System (STAR Ankle)
Sponsors: Small Bone Innovations, Inc.; Small Bone Innovations, Inc.
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Milnacipran
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Forest Laboratories
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methylprednisolone
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: LY2127399
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: Rituximab; Drug: Placebo
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified June 2011 - Condition: Arthritis, Rheumatoid
Intervention:
Sponsors: Biogen Idec; Biogen Idec; Crescendo
Recruiting - verified March 2012 - Condition: Arthritis
Interventions: Other: Blood samples; Other: Synovial fluid aspiration; Other: Synovial tissue sample
Sponsors: MedImmune LLC; MedImmune LLC; AstraZeneca
Recruiting - verified January 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: Part 1: Etoricoxib 60 mg; Drug: Part 1: Etoricoxib 90 mg; Drug: Part 2: Etoricoxib 60 mg; Drug: Part 2: Etoricoxib 90 mg; Drug: Part 1: Placebo to Etoricoxib 60 mg; Drug: Part 1: Placebo to Etoricoxib 90 mg; Drug: Part 2: Placebo to Etoricoxib 60 mg; Drug: Part 2: Placebo to Etoricoxib 90 mg
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Arthritis, Rheumatoid
Intervention: Drug: Milnacipran
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Forest Laboratories; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Device: Ultrasonography
Sponsors: Diakonhjemmet Hospital; Espen A. Haavardsholm; The Research Council of Norway; Smerud Medical Research International AS; Oslo University Hospital, Section for GCP; Innovest; Abbott; UCB NORDIC A/S; Pfizer; MSD Norway AS; Roche Pharma AG; The Norwegian Rheumatism Association
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo
Sponsors: Centocor, Inc.; Centocor, Inc.; Schering-Plough (Ireland) Company
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: fostamatinib; Drug: fostamatinib; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Arthritis, Rheumatoid; Pain; Fatigue
Interventions: Drug: adalimumab; Drug: Placebo
Sponsors: Karolinska Institutet; Karolinska Institutet; Abbott; Swedish Foundation for Strategic Research; The Swedish Research Council
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Biological: apremilast; Other: Placebo
Sponsors: Baylor Research Institute; Baylor Research Institute
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Interventions: Biological: Humira (adalimumab); Drug: Methotrexate (MTX)
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Early Rheumatoid Arthritis
Interventions: Biological: adalimumab; Drug: methotrexate
Sponsors: Abbott; Abbott
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: randomisation
Sponsors: Universitaire Ziekenhuizen Leuven; P. Verschueren; Het agentschap voor Innovatie door Wetenschap en Technologie (IWT)
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Tasocitinib plus Methotrexate; Drug: Tasocitinib plus placebo methotrexate; Drug: Placebo tasocitinib plus Methotrexate
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Diacerein; Drug: Placebo
Sponsors: TRB Chemedica; TRB Chemedica
Recruiting - verified October 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche; Clalit Health Services
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Methotrexate; Drug: Abatacept Placebo; Drug: Methotrexate Placebo
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Insulin Resistance
Intervention: Drug: Hydroxychloroquine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab; Drug: Methotrexate
Sponsors: Abbott; Abbott; Mount Sinai Hospital, Canada
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: APL A12
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Abbott; Abbott; University Health Network, Toronto
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Cardiovascular Disease
Intervention:
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified December 2011 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Interventions: Procedure: Minimally Invasive Anterior Approach; Procedure: Standard postero-lateral approach
Sponsors: Medacta International SA; Medacta International SA
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab
Sponsors: University of Rochester; University of Rochester
Recruiting - verified October 2011 - Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; University of California, San Diego; The Organization of Teratology Information Specialists; Abbott
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University of Rochester; University of Rochester
Recruiting - verified June 2011 - Conditions: Rheumatoid Arthritis; Osteoarthritis; Post-traumatic Arthritis; Avascular Necrosis; Traumatic Femoral Fractures; Congenital Hip Dysplasia
Intervention: Device: DePuy Proxima™ Hip
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.
Sponsors: Abbott; Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.
Recruiting - verified February 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2012 - Conditions: Active Rheumatoid Arthritis; Osteoporoses
Intervention:
Sponsors: Abbott; Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2012 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeCondition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [Mabthera/Rituxan]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Condition: Arthritis, Rheumatoid
Interventions: Drug: Otelixizumab; Drug: Matching placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [Mabthera/Rituxan]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis
Interventions: Device: Vanguard CR; Device: AGC knee
Sponsors: Biomet, Inc.; Biomet, Inc.; Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK); Biomet U.K. Ltd.
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: SAR153191 (REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention: Drug: anti-TNF therapy (etanercept or adalimumab)
Sponsors: Imperial College London; Imperial College London
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: AMG 827
Sponsors: Amgen; Amgen
Not yet recruiting - verified July 2011 - A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisCondition: Rheumatoid Arthritis
Interventions: Drug: CAM3001; Drug: CAM3001; Drug: CAM3001; Drug: CAM3001
Sponsors: MedImmune LLC; MedImmune LLC; MedImmune Ltd
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Other: MRI
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: CF101; Drug: Placebo control
Sponsors: Can-Fite BioPharma; Can-Fite BioPharma
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: placebo TCZ; Drug: placebo MTX
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: non-biological DMARDs
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Intervention: Drug: Adalimumab
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen
Recruiting - verified March 2012 - Condition: Active Rheumatoid Arthritis
Intervention: Drug: SBI-087
Sponsors: Pfizer; Pfizer; Emergent Product Development Seattle LLC
Recruiting - verified April 2012 - Conditions: Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases
Interventions: Drug: golimumab or placebo; Drug: golimumab; Drug: golimumab or placebo; Drug: golimumab; Drug: golimumab or placebo
Sponsors: Centocor, Inc.; Centocor, Inc.; Merck
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Other: Neuromuscular electrical stimulation; Other: Volitional exercises
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified September 2011 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Endothelial Dysfunction; Inflammatory Disease Activity
Intervention:
Sponsors: Revmatismesykehuset AS; Revmatismesykehuset AS; Abbott
Recruiting - verified May 2009 - Condition: Rheumatoid Arthritis
Interventions: Drug: Methotrexate; Drug: Infliximab
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified February 2012 - Conditions: Psoriasis; Coronary Artery Disease
Intervention: Procedure: CCTA Scan (Coronary CT Angiogram)
Sponsors: University of Michigan; University of Michigan
Recruiting - verified August 2011 - Conditions: Polymyalgia Rheumatica; Rheumatoid Arthritis; Rheumatic Disease
Intervention:
Sponsors: Lahey Clinic; Lahey Clinic
Recruiting - verified February 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-traumatic Arthritis
Interventions: Procedure: Navigated TKA with a minimally invasive approach; Procedure: Navigated TKA with a conventional approach
Sponsors: Aesculap AG; Aesculap AG
Recruiting - verified July 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Adalimumab
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: Naproxen
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Juvenile Idiopathic Arthritis; Systemic Lupus Erythematosus; Juvenile Dermatomyositis
Intervention: Drug: Human papilloma virus vaccine (cervarix)
Sponsors: UMC Utrecht; N.M. Wulffraat; National Institute for Public Health and the Environment (RIVM)
Recruiting - verified August 2011 - Condition: Juvenile Idiopathic Arthritis
Intervention: Other: Withdrawal of anti-TNF therapy
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Avascular Necrosis; Traumatic Arthritis; Rheumatoid Arthritis
Intervention: Procedure: metal on metal hip arthroplasty
Sponsors: Biomet, Inc.; Biomet, Inc.; Biomet U.K. Ltd.
Not yet recruiting - verified May 2012 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: adalimumab; Drug: Methotrexate
Sponsors: Abbott; Abbott
Recruiting - verified April 2012 - Condition: Arthritis, Rheumatoid
Interventions: Procedure: Laser Based Photoacoustic Tomography, MRI, Ultrasound; Procedure: laser based photoacoustic tomography, MRI, ultrasound
Sponsors: University of Michigan; University of Michigan
Recruiting - verified May 2012 - Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis
Intervention: Device: Cormet Hip Resurfacing
Sponsors: Corin; Corin
Recruiting - verified June 2011 - Conditions: Crohn Disease; Arthritis, Rheumatoid
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified January 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: pioglitazone
Sponsors: University of Michigan; University of Michigan; National Institutes of Health (NIH)
Recruiting - verified October 2011 - Condition: Arthritis
Interventions: Biological: Gardasil; Biological: Gardasil; Biological: Gardasil
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Merck
Recruiting - verified October 2011 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Septic Arthritis; Prior Ankle Fusion
Intervention: Device: ankle joint replacement
Sponsors: Tornier; Tornier
Recruiting - verified June 2010 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Conditions: Pulmonary Hypertension; Connective Tissue Disease
Intervention: Behavioral: exercise training
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified March 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Interventions: Drug: Celecoxib; Drug: non-selective Non steroidal anti inflammatory Drug
Sponsors: University of Dundee; University of Dundee; University of Glasgow; University of Nottingham
Recruiting - verified May 2012 - Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Autoimmune Pancytopenia; Autoimmune Lymphoproliferative Syndrome (ALPS); Evans Syndrome; Idiopathic Thrombocytopenic Purpura; Anemia, Hemolytic, Autoimmune; Autoimmune Neutropenia; Lupus Erythematosus, Systemic; Inflammatory Bowel Disease; Rheumatoid Arthritis
Intervention: Drug: sirolimus
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified May 2012 - Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; Pfizer; The Cleveland Clinic
Recruiting - verified May 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Radboud University; Radboud University
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Lovastatin; Device: Lovastatin placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence
Recruiting - verified September 2011 - Condition: Rheumatoid Arthritis
Intervention: Biological: Hematopoietic Stem Cell Transplantation
Sponsors: Northwestern University; Richard Burt, MD
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified August 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Conditions: Rheumatic Diseases; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Scleroderma; Dermatomyositis; Myositis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified November 2011 - Conditions: Rheumatic Diseases; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified January 2012 - Conditions: Arthritis; Synovitis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified October 2011 - Conditions: Sjogren's Syndrome; Xerostomia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified October 2011
 |
Join Clinical Trials for Rheumatoid Arthritis, and other forms of Arthritis |
